Small Intestinal NET clinical trials at UC Irvine
1 in progress, 0 open to eligible people
Sorry, not currently recruiting here
This is a Phase 2, open-label, multi-centre study of surufatinib in patients with low to intermediate grade (Grade 1 or Grade 2), well-differentiated neuroendocrine tumours (NETs).
Orange, California and other locations